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Details of the methods employed to titrate separately the total plasmin and 
the trypsin inhibitor in human blood serum are given in the preceding paper 
(Todd, 1948); and the precautions necessary to allow independent titrations of 
total plasmin are described.  Evidence is presented that by these methods an 
approximation to  the  separate  titration  of enzyme and  inhibitor  in  a  single 
sample of serum can be made. 
The results of using these methods to follow variations in the levels of plasmin 
and inhibitor in blood taken at weekly intervals from scarlet fever patients are 
given in this paper.  The same lots of azocoll, of streptokinase (S.K.A.I.), and 
of crystalline trypsin, described in the preceding paper, were again used in the 
following titrations.  It was therefore possible, by employing these standard- 
ized  reagents,  to  obtain  comparable  results  for  the  different  groups  of 
streptococcal diseases investigated. 
The source of the  sera was described  in  the  preceding paper.  They were 
taken from young men of the same age group who were admitted to the hospital 
of the  Great Lakes Naval Training  Center with  scarlet fever during  March 
and  April,  1946.  All  the  bleedings were taken  before breakfast in  order  to 
obtain clear sera and to avoid the high levels of inhibitor which are known to 
occur after meals.  Samples of serum were taken on admission to the hospital 
and  thereafter  at  weekly intervals  from 380  scarlet fever patients.  Only  a 
small number of these sera could be titrated for plasmin and inhibitor owing 
to limited supplies of standardized azocoll and streptokinase.  Sera from rheu- 
* This work was commenced  while the author was a Visiting Investigator at the Hospital of 
The Rockefeller Institute  for Medical Research supported by a grant made to the British 
Medical Research Council by the WeUcome  Trustees and assisted in part by a contract between 
The Rockefeller Institute  for Medical Research and the Commission  on Hemolytic Strepto- 
coccal Infections, Board for the Investigation and Control of Influenza and Other Epidemic 
Diseases in the Army, Preventive Medicine Service, O~ce of The Surgeon General, United 
States Army.  Continuation of the work was supported (in part) by a research grant from the 
United States Public Health Service at The Rheumatic  Fever Research Institute,  North- 
western University, Chicago. 
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matic subjects  with no evidence of active disease were also included in this 
investigation.  1 
Four groups of cases were studied; the numbers of patients in each group 
were  as  follows: Uncomplicated  scarlet  fever,  7;  scarlet  fever  followed by 
purulent complications, 6; scarlet fever followed by rheumatic fever, 15; rheu- 
matic children with no evidence of active disease, 2. 
The results of titrations of total plasmin and of trypsin inhibitor in the sera 
will be presented in a series of charts so that the relation of plasmin and inhibitor 
to each other can be compared in the different diseases investigated.  In these 
charts the abscissae give the times when each patient was bled.  Light lines 
indicate a  final late sample of serum taken after the patient had returned to 
duty.  The ordinates of the  charts  represent  (1)  the  number of color units 
released by the activated plasmin of the serum from 30 mg. of azocoll, (2) the 
percentage  inhibition  of  crystalline  trypsin  by  the  serum.  The  numerals 
obtained in the titration of plasmin and of inhibitor happen to fall in the same 
range.  It is therefore convenient for purposes of comparison to plot curves of 
plasmin and inhibitor by reference to a single scale of ordinates.  The erythro- 
cyte sedimentation rate for each sample of blood is recorded in numerals at the 
top  of each  chart  above the  corresponding curves.  These figures represent 
sedimentation after 1 hour determined by the Cutler method which, as is well 
known,  gives  lower readings  than  the  Westergren  method. 
EXPER~ENTAL RESULTS 
Titrations  of Sera from Patients  with Uncomplicated Scarlet Fever 
In Fig.  1 Charts  1 a  to 1 g give the total plasmin and the trypsin inhibitor 
levels of sera from 7 patients with uncomplicated scarlet fever.  Referring to 
individual cases it will be seen that 5 of the charts namely 1 a to 1 e inclusive 
show a  marked  tendency to parallelism  between the  two  curves.  In  other 
words a rise or a fall in one of the curves is accompanied by a similar change in 
the other curve.  It is also noteworthy that in all 5 cases the plasmin curves 
occupy higher  levels on  the  charts  than  the  corresponding inhibitor  curves 
throughout the periods of observation.  In Chart  1 f  the inhibitor curve was 
higher than the plasmin curve during the first 2 weeks.  This relationship was 
reversed by an increase of plasmin and a fall of inhibitor during the 2nd week. 
After 3 weeks the patient returned to duty; 14 weeks later, when the patient 
was finally examined, the relative levels of plasmin and inhibitor were similar 
to those found when he was first admitted to the hospital.  In Chart  1 g a 
relatively high plasmin level was accompanied by a constant low inhibitor level 
during the first 3 weeks.  During the 4th week a steep fall of plasmin level was 
accompanied by an increase of inhibitor. 
1 These sera were made available through the kindness of Dr. Sidney Rothbard. EDGAR  W.  TODD  311 
Titrations of Sera from Patients with Scarlet Fever and Purulent Complications 
In Fig.  2 Charts 2 a  to 2f give the total plasmin and the trypsin inhibitor 
levels of sera from 6 scarlet fever patients who developed purulent  complica- 
tions.  Chart 2 a gives plasmin and inhibitor levels of sera from a scarlet fever 
patient who developed a purulent streptococcal infection of the urinary  tract. 
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FIa. 1.  Results of titrating sera from 7 patients with uncomplicated  scarlet fever.  Charts a 
to g.  In al charts the ordinates give the plasmin levels  of sera expressed  as color  units recorded 
thus e----o and the percentage inhibition of trypsin by the sera recorded thus O--O.  Abscis- 
sae give time in weeks from the onset of scarlet fever which is recorded as zero.  The numerals 
at the top of each chart, above the curves, give erythrocyte sedimentation rates (Cutler method) 
at the time of bleeding.  S =  uncomplicated scarlet fever. 
The final sample of serum, taken after 3 weeks, had an antistreptokinase titre 
of 1/5000 which was the highest titre encountered among al the sera examined. 
In this case the curves of plasmin and inhibitor were roughly parallel; and the 
inhibitor levels were either slightly above or coincided with the plasmin levels. 
Charts  2 b  to  2 e  inclusive give plasmin and  inhibitor  levels of sera from  4 
scarlet fever patients who developed otitis media.  Chart 2f gives plasmin and 
inhibitor levels of sera from a scarlet fever patient who contracted  pharyngitis 
during the 3rd week due to hemolytic streptococci of a serological type different 
from the original infecting organism.  He developed maxillary sinusitis 6 weeks 
after admission to the hospital. 312  TOTAL PLAS}~IN AND  TRYPSIN INHIBITOR.  II 
Comparing Fig. 2 with Fig. 1, it will be seen that with purulent complications 
there is a  tendency for the plasmin and inhibitor curves to be more closely 
approximated  than  in  uncomplicated  scarlet  fever.  Fig.  2  again  shows  a 
general tendency for the two curves to be roughly parallel although this is less 
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FIG. 2.  Results of t~trating Bera  from 6 patients with scarlet fever who developed  purulent 
complications.  Charts a to f.  S --+ U  =  scarlet fever followed by purulent streptococcal 
infection of urinary tract.  S --~ O =  scarlet fever followed by otitL~  media.  S --+ T --* M  = 
scarlet fever followed by tonsillitis due to reinfection by hemolytic streptococcus  of different 
serological type, followed by maxillary sinusitis.  0  =  week when otitis media was recorded. 
M =  time when maxillary sinusitis was recorded. 
evident than in uncomplicated scarlet fever.  Among the purulent cases the 
plasmin curves are usually at a higher level than the inhibitor curves although 
this does not apply to the first 2 weeks in Charts 2 a and 2 d or to the 1st week 
in Chart 2 b.  Charts 2 e and 2f resemble those of rheumatic fever; they will be 
discussed in a subsequent section. 
Titrations of Sera from Patients with Scarlet Fever Followed by Rheumatic  Fever 
In Fig. 3 Charts 3 a to 3f give the total pl~smin and the trypsin  inhibitor 
levels of sera from 6 patients with scarlet fever followed by rheumatic fever. 
The time of onset of the rheumatic attack is indicated by a vertical interrupted 
line.  All the figures show a low plasmin level and a high inhibitor level at the EDGAR  W.  TODD  313 
time of the rheumatic attack.  In Charts 3 a, b, c, and e the maximal divergence 
between plasmin and  inhibitor levels  occurred at  the  time  of the  rheumatic 
onset.  In Chart 3 d the plasmin level continued falling and the inhibitor level 
continued rising after the onset of rheumatic fever; the erythrocyte sedimenta- 
tion rate  also  continued rising.  In  Chart  3f  there  was  a  steep  rise  of  the 
inhibitor level during the 6th week without any obvious reason. 
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Fio. 3.  Results of titrating sera from 6 patients with scarlet fever who developed  rheumatic 
fever.  Charts a to f.  S ~  R  -  scarlet fever followed by rheumatic fever.  The vertical 
interrupted  lines indicate times of  onset of  rheumatic fever.  A  =  week when arthritis 
appeared.  C = week  when carditis was recorded.  P -- week  when pericarditis was recorded. 
In each case the rheumatic onset occurs  when the plasmin level is low and the inhibitor level is 
high. 
In Fig. 4 Charts 4 a  to 4 d give the total plasmin and the trypsin inhibitor 
levels in sera from 4 patients with scarlet fever who developed rheumatic fever. 
In each case the rheumatic onset occurred when a relatively low plasmin ]evel 
coincided with a relatively high inhibitor level.  In Chart 4 a the plasmin level 
was at its lowest at the time of the rheumatic onset.  At this time the inhibitor 
level was rising and it continued to rise  until it reached its highest level at the 
time of the maximal erythrocyte sedimentation rate.  In Chart 4 b the plasmin 
level fell  slightly while the inhibitor level rose steeply until they almost coin- 
cided at the time of the rheumatic onset.  In Chart 4 c the plasmin level fell 314  TOTAL PLASMIN AND TRYPSIN INHIBITOR.  II 
while the inhibitor  level rose slightly until  they coincided at the time of the 
rheumatic  attack. 
Chart 4 d, which is marked S --~ 0  --~ R, gives details of a particularly inter- 
esting  case.  This  patient  was  admitted  to  the  hospital  with  scarlet  fever. 
During weeks 1 to 4 he suffered from otitis media; he was convalescent in the 
5th week and then returned to duty.  During the 9th week he was readmitted 
to  the  hospital  with  acute  rheumatic  fever.  Group  A  type  17  hemolytic 
streptococci were isolated from his nasopharynx on two occasions during weeks 
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Fro. 4. Results of titrating sera from 4 patients with scarlet fever who developed  rheumatic 
fever.  Charts a to d.  S ~  R =  scarlet fever followed by rheumatic fever.  S --~ O --~ R = 
scarlet fever followed  by otitis media followed  by rheumatic fever.  In each case the rheumatic 
onset occurs when a relatively low plasmin level coincides  with a relatively high inhibitor level. 
0 and 1; they were replaced during week seven by group A type 1 streptococci. 
On admission to the hospital he had an unusually large amount of inhibitor in 
his serum.  During the course of otitis media, which  lasted for 4  weeks, the 
plasmin level rose steeply and the inhibitor level fell steeply so that the curves 
crossed in the 3rd week.  During convalescence from otitis media the plasmin 
level fell steadily while the inhibitor level rose steeply until they reached maxi- 
mal  divergence  at  the  9th  week  when  rheumatic  arthritis  made  its first 
appearance. 
In Fig. 5 Charts 5 a  to 5 e give the total plasmin and the trypsin inhibitor 
levels of sera from 5 patients with scarlet fever followed by rheumatic fever. 
Chart 5 a records uniformly low plasmin levels and high inhibitor levels through- 
out the whole course of the disease without any special change in the shapes of 
the curves at the  time of the rheumatic attack.  In Chart  5 b arthritis  and 
carditis occurred at the end of the 2nd week when a  high plasmin level coin- EDGAR  W.  TODD  315 
cided with a  low inhibitor level.  This was followed by a  fall of plasmin and 
a  rise of inhibitor until their levels coincided at the time when the erythrocyte 
sedimentation  rate  was  at  its  maximum.  Thereafter,  a  fall  of  erythrocyte 
sedimentation  rate  was accompanied by a  rise  of plasmin  and  a  gradual  fall 
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Fxo. 5. Results of fitrating sera from 5 patients with scarlet fever who developed rheumatic 
/~o 
fever.  Charts a to e.  S ~  R -- scarlet fever followed by rheumatic fever.  S,,,~  R =  scarlet 
fever followed by otitis media and rheumatic fever at the same time.  A == arthritis.  C = 
cardifis.  0  --- otitis media.  In each case the inhibitor level was higher than the plasmin 
level, or the two levels coincided, at the time of the maximal blood sedimentation rate following 
the onset of rheumatic fever. 
of inhibitor.  In  Chart  5 c  the  vertical  interrupted  line  is  omitted  owing to 
difficulty in determining  the  exact  date  of rheumatic  onset.  There was evi- 
dence of carditis  during  the first  2  weeks and  the  erythrocyte sedimentation 
rate was at its maximum during the 2nd week.  At this  time a  high plasmin 
level coincided with a  still higher inhibitor level.  The first attack of arthritis 
occurred in the 5th week when the plasmin level had fallen slightly while the 
inhibitor  level  had  fallen  steeply,  gNing  the  unusual  picture  of  arthritis 
occurring at a time when the inhibitor level was considerably below the plasmin 
level.  A  second attack of arthritis occurred a fortnight later; at this time the 316  TOTAL PLASMIN AND TRYPSIN INHIBITOR.  n 
plasmin and inhibitor levels were characteristically divergent with the lowest 
plasmin level recorded during the course of the disease. 
O 
Chart 5 d, which is marked S  , gives results for a  patient who developed 
R 
otitis media and rheumatic polyarthritis at the same time during  the first 2 
weeks of scarlet fever.  During this time the plasmin level was high while the 
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FIG. 6. Results of titrating sera from 2 rheumatic subjects with no evidence of rheumatic 
activity.  Charts a and b.  Abscissae  give time in months during which children were under 
observation in the hospital; the date of admission  is recorded as zero.  The numerals at the top 
of each chart, above the curves, give erythrocyte sedimentation rates, Westergren method, at 
the time of bleeding.  RSQ -- rheumatic subject quiescent.  In both cases the plasmin level 
was higher than the inhibitor level. 
inhibitor level was relatively low.  In the 3rd week the highest sedimentation 
rate was reached and at the same time the plasmin level was at its lowest and 
the inhibitor level at its highest. 
In Chart 5 e rheumatic arthritis and carditis occurred during  the  1st week 
with  a  high  plasmin level and  a  relatively low  inhibitor  level.  During  the 
following week, when the sedimentation rate reached its maximum, the plasmin 
fell while the inhibitor rose to its highest point. 
Titrations  of Sera from Rheumatic  Subjects wit,k No Evidence of Active Disease 
In Fig. 6 Charts 6 a and 6 b give the total plasmin and the trypsin inhibitor 
levels of sera from 2 rheumatic children who did not show any signs of rheu- 
matic  activity  or  of  infection  during  the  6  months  while  they  were  under 
observation and who had steadily falling antistreptolysin 0  titres during  this EDGAR w.  WODD  317 
time.  These sera were taken during the period October, 1940, to March, 1941; 
they had been stored in the cold for 8 years before titration for plasmin and 
inhibitor.  The first of these children  (Chart  6 a)  was  a  girl aged  11  whose 
previous rheumatic attack occurred 3  years earlier.  Samples of serum were 
taken about once a month during 6 months' observation.  It will be seen from 
Chart 6 a that the plasmin levels were high throughout in relation to inhibitor 
levels.  The second child was a boy aged 10 whose previous rheumatic attack 
occurred 17 months earlier.  Samples of his serum were taken about twice a 
month.  Chart 6 b shows plasmin levels which were again high in relation to 
inhibitor.  The  erythrocyte sedimentation  rates  for  the  two  children  were 
determined by the Westergren method. 
Figs. 1 to 6 show that the charts of plasmin and inhibitor levels for this series 
of patients had a characteristic pattern in active rheumatic fever due to a fall 
of the plasmin level accompanied by a  rise of the inhibitor level during the 
period of rheumatic activity.  This rarely occurred in streptococcal diseases 
when rheumatic symptoms were not observed.  Thus Fig. 1 shows that among 
7 cases of uncomplicated scarlet fever, comprising 32 titrations of plasmin and 
inhibitor, the plasmin level was below the inhibitor level on only 4 occasions. 
In Fig. 2 which gives the plasmin and inhibitor levels of 6 scarlet fever patients 
with  purulent  complications  there  are  2  charts,  namely  2 e  and  2f,  which 
resemble those of rheumatic fever patients.  Thus in Chart 2 e a rise of inhibitor 
coincided with a fall of plasmin in the 2nd week; in Chart 2 f  the inhibitor curve 
rose slightly above the plasmin curve during weeks 3 and 4.  Turning now to 
Figs.  3,  4,  and 5 which give the plasmin and inhibitor levels for 15 patients 
with scarlet fever followed by rheumatic fever, it will be seen that in every case 
there was  a  change in the relative levels of the  two curves coinciding either 
with the time of rheumatic onset or with the time of the maximal erythrocyte 
sedimentation rate after the onset of the rheumatic attack.  This characteristic 
change was a fall of the plasmin level accompanied by a rise of the inhibitor level. 
The possibility that the fall of the plasmin level at the onset of the rheumatic 
attack might be caused by a large amount of antistreptokinase in the blood at 
that time deserves consideration.  It was shown in the preceding paper that 
the antistreptokinase titres of the sera did not influence the determination of 
plasmin levels under the experimental conditions adopted.  Further evidence 
on this point is now supplied by the figures in Table I which give the antistrepto- 
kinase titres  2 of the sera used in the p]asmin and inhibitor titrations which are 
recorded in Figs. 1 to 5.  Comparison of Table I  with Charts 1 a to 5 e shows 
that there is no correlation between the antistreptokinase titres and the plasmin 
levels.  In Table I, column 1 gives the case numbers used by Anderson, Kun- 
kel,  and  McCarty  (1948);  column 2  gives  the identification numbers of the 
2 The anfistreptokinase titres were determined  by Dr. H. C. Anderson  and Dr. M. McCarty 
who kindly allowed the use of their data. 318  TOTAL PLASMIN AND TRYPSIN INHIBITOR.  II 
charts  of  plasmin and  inhibitor levels recorded  in  this  paper;  the  last  five 
columns give the reciprocals of the antistreptokinase titres of the sera at weekly 
intervals following the onset of scarlet fever. 
TABLE I 
Reciprocals  of the Antistreptokinase  Titres of Sofa  Used for Pla~min and Inhibitor Tilrations 
Case No. 
279 
49 
3O4 
108 
123 
131 
288 
22 
305 
287 
249 
114 
196 
16 
61 
52 
13 
51 
251 
120 
23 
42 
45 
30 
234 
44 
65 
181 
Chart 
Za 
lb 
lc 
ld 
le 
If 
lg 
2e 
2b 
2¢ 
2d 
2e 
2/ 
3a 
3b 
3c 
3d 
3e 
3/ 
4e 
4b 
4c 
4d 
5a 
5b 
5c 
5d 
5e 
80 
40 
40 
0 
40 
20 
40 
20 
160 
0 
320 
160 
40 
20 
320 
160 
8O 
40 
0 
80 
4O 
40 
40 
40 
80 
160 
2O 
40 
Titres at the following times in weeks dating from the 
onset of scarlet fever 
80 
4O 
80 
40 
320 
40 
40 
320 
2O 
64O 
1280 
8O 
2O 
320 
160 
8O 
40 
0 
8O 
160 
8O 
8O 
320 
160 
160 
20 
160 
160 
40 
80 
80 
320 
40 
64O 
160 
40 
640 
1280 
8O 
160 
2560 
320 
320 
8O 
80 
320 
640 
80 
160 
80 
320 
160 
160 
320 
320 
8O 
8O 
160 
160 
320 
40 
5120 
160 
40 
64O 
1280 
320 
2560 
640 
1280 
320 
64O 
64O 
640 
80 
2O 
8O 
64O 
320 
640 
320 
4-6 
320 
•o. 
8O 
160 
160 
..• 
8O 
160 
64O 
1280 
256O 
320 
256O 
64O 
2560 
64O 
1280 
1280 
64O 
8O 
160 
8O 
64O 
64O 
64O 
320 
•.. ---- not done. 
The characteristic patterns of the plasmin and inhibitor curves can be more 
easily recognized by referring  to  Fig.  7  which  records  on  three  charts  the 
arithmetic means of  the  plasmin and  inhibitor levels of  the  three  different 
groups of scarlet fever patients•  Thus  Fig. 7 a  gives the average levels for 7 
cases of uncomplicated scarlet fever; Fig. 7 b gives averages for 6 cases compli- 
cated  by suppuration and Fig.  7 c  gives averages  for  14  cases  followed  by 
rheumatic  fever.  The  fifteenth  case  of  rheumatic  fever,  namely 4d,  was EDGAR W.  TODD  319 
omitted  from  Chart  7 c  because  the  onset  of  rheumatic  fever  in  this  case 
occurred 10 weeks after admission to the hospital.  Fig.  7 is constructed in a 
similar way to those already described.  The ordinates give color units released 
by plasmin and the percentage inhibition of trypsin.  The abscissae give weeks 
after admission to the hospital.  The average time of rheumatic onset for the 
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FIo.  7. Arithmetic means  of plasmin  and inhibitor levels  of 7 patients with uncomplicated 
scarlet fever (Chart a); of 6 patients with scarlet fever followed by purulent complications 
(Chart b); and of 14 patients  with scarlet  fever followed  by rheumatic  fever (Chart ¢).  In the 
uncomplicated  and purulent groups  the curves  do not cross.  In the rheumatic  group  the curves 
cross at the 3rd and 4th weeks. 
14  cases  represented  in  Chart  7 c  was  the  3rd  week  after  admission  to  the 
hospital. 
It will be seen from Chart 7 a that the average plasmin and inhibitor curves 
for  uncomplicated  cases  of  scarlet  fever run  approximately parallel  courses 
with plasmin at a uniformly higher level than inhibitor.  Chart 7 b shows that 
the average curves for patients with purulent complications are closer together 
than in Chart  7 a  but they do not  cross.  Chart  7 c shows that the average 
curves for rheumatic fever cases cross at the 3rd week when plasmin is at its 
lowest and inhibitor is at its highest. 
Fig. 7 allows a direct comparison of curves obtained with sera from the three 
different groups of patients based on the date of onset of scarlet fever but it 320  TOTAL PLASMTN AND  TRYPSIN INHIBITOR.  II 
might tend to obscure the characteristic rheumatic pattern because the dates 
of onset of rheumatic symptoms after admission to the hospital varied from 1 
to 6 weeks. 
Fig. 8 was therefore constructed to give averages for plasmin and inhibitor 
levels in rheumatic fever cases based on the times of onset of rheumatic symp- 
toms and on the dates of maximal erythrocyte sedimentation rates.  Thus in 
Chart  8 a  the  vertical interrupted  line  gives the  date  of onset of rheumatic 
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FIG. 8. Arithmetic means of the plasmin and inhibitor levels of 15 patients with scarlet 
fever followed by rheumatic fever.  Abscissae  in Chart ~ give time in weeks before and after 
the date of onset of rheumatic fever which is recorded as zero and indicated by a vertical 
interrupted line.  In Chart b, which is based on the date of the maximal erythrocyte  sedimenta- 
tion rate after the onset of rheumatic fever, abscissae give time in weeks before and after the 
date of maximal erythrocyte sedimentation rate which is recorded as zero and indicated by a 
vertical interrupted line.  ESR. ~  erythrocyte sedimentation rate. 
symptoms.  This point is recorded as zero on the base line and the preceding 
and succeeding weeks are numbered in succession dating from the time of the 
rheumatic attack.  Similarly in  Chart  8 b the vertical interrupted  line gives 
the date of maximal blood sedimentation rates following the onset of rheumatic 
fever and it supplies the zero base line from which weekly intervals are num- 
bered in both directions.  Fig. 8 gives the averages of all of the 15 rheumatic 
cases examined. 
It will be seen from Fig. 8 that the characteristic fall of plasmin and rise of 
inhibitor occur in both sets of curves.  In Chart 8 a which is based on the first 
appearance  of rheumatic  symptoms,  the  inhibitor  curve remains  above  the 
plasmin curve for 3 weeks; Chart 8 b which is based on maximal erythrocyte EDGAR  W.  TODD  321 
sedimentation rates  shows a  preponderance  of inhibitor over  plasmin  for 2 
weeks. 
An attempt was  made to determine from the figures presented in Fig.  7 
whether the divergence of plasmin and inhibitor curves which occurs in rheu- 
matic fever is principally  due to a fall of plasmin or to an increase of inhibitor. 
Table II shows that when all the points on each of the three curves shown in 
Fig. 7 were averaged,  uncomplicated scarlet fever had the highest plasmin and 
the lowest inhibitor levels.  Comparing these figures for uncomplicated scarlet 
TABLE  II 
Showing Quantitative Changes of Total Plasmin  and of Trypsin Inhibitor in Uncomplicated 
Scarlet Fever, in Cases Complicated by Purulent Infections, and in 
Cases Followed  by Rheumatic Fever 
7a ¸ 
7b 
7c 
7a 
7b 
7¢ 
Csses included in 
each chart 
Uncomplicated 
Purulent 
Rheumatic 
Uncomplicated 
Purulent 
Rheumatic 
Points on curves which were included 
in averages 
Average of whole length of curve 
L~  ¢~  ~  ~c  cc  cc 
At wk. 4 only 
cC  tc  c~  ~t 
?lamuin Inhibitor 
levels  I  levels 
9157149118[31[26 
7[51]42[30[43136 
815.  2. I~2013.  51.44.1~91 
Differences 
of mean 
levels com- 
t~ed with 
of un- 
complicated 
scarlet fever 
Pls.s- [nhib- 
mm  itor 
i 
+io 
+13 
2  +~0 
--111  +23 
fever with the means of the corresponding plasmin and inhibitor levels shown 
in Charts 7 b and 7 c it will be seen that the purulent cases differed from un- 
complicated  cases in plasmin and in inhibitor respectively  by --7 and +10 
while the rheumatic cases differed by --7 and +13.  There was therefore no 
very marked difference between  purulent and rheumatic cases if the whole 
course  of the disease  was  considered.  On  the other hand, a  much greater 
difference appeared when the same procedure  was applied  to the averages  of 
the 4th week only.  Thus, when compared  with uncomplicated scarlet fever, 
the purulent cases showed plasmin and inhibitor changes respectively  of --9 
and +10 and rheumatic cases --11 and +23.  This shows that although the 
average  level of plasmin  is diminished and that of inhibitor increased during 
the whole course of both septic and rheumatic cases, yet this phenomenon is 
most conspicuous at the time of the rheumatic attack.  It also shows that 
excess of inhibitor is greater than diminution of plasmin at the time when 
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DISCUSSION 
Evidence was presented in the preceding paper (Todd, 1948) that the total 
plasmin in human  serum  could be estimated by determining its proteolytic 
action on azoco]l after the plasminogen had been activated by a suitable excess 
of streptokinase.  It was also shown that titrations of total plasnfin in human 
serum were not materially affected either by the trypsin inhibitor in the serum 
if special methods were adopted or by the antistreptokinase in the serum if 
its titre was less than 1/5000. 
The present  paper  gives  the  results  of titrations  of total plasmin  and  of 
trypsin inhibitor in sera taken at intervals from four different groups of patients, 
namely,  uncomplicated  scarlet fever, scarlet  fever complicated by purulent 
infections,  scarlet  fever followed by rheumatic fever, and  finally rheumatic 
children with no evidence of active rheumatic disease.  The results of plotting 
curves of the total plasmin and of the trypsin inhibitor levels during the course 
of these diseases showed that in those cases where rheumatic symptoms were 
not  manifested there was  a  general tendency for the plasmin  and  inhibitor 
curves to follow similar courses with corresponding elevations or depressions 
occurring at about the same time.  This suggests the possibility that a  rise 
or a fall in the level of total plasmin is normally compensated by a similar rise 
or fall of inhibitor so that excess of plasminogen is accompanied by excess of 
inhibitor while a low plasminogen content tends to coincide with a low inhibitor 
level.  If such a compensatory mechanism exists, it appears to break down in 
rheumatic fever so that a  fall of plasmin and a  rise of inhibitor occur at the 
same time.  In other words, the normal relative levels of plasmin and inhibitor 
are reversed in rheumatic fever and this change usually takes place either at 
the time when the first rheumatic symptoms appear or at a  subsequent date 
when the blood sedimentation rate reaches its maximum. 
The tentative hypothesis that plasmin and inhibitor are normally linked by 
a  compensatory mechanism and  that  this mechanism breaks down in rheu- 
matic fever cannot be substantiated  until  figures are  available  to show  the 
re]ation of p]asmin to inhibitor in sera taken at intervals from normal people 
and from patients with diseases other than those due to streptococcal infections. 
Unfortunately these titrations could not be included in the present investiga- 
tion owing to limited supplies of standardized steptokinase and azocoll.  The 
number of titrations of plasmin and inhibitor which were actually carried out 
was necessarily small for the same reason.  It is hoped that a larger number of 
sera will be titrated later with fresh lots of streptokinase and azocoll. 
Diseases caused by streptococci occupy a special category in an investigation 
of serum plasmin  levels because  the  only substance  which  is  known  at  the 
present  time  to  be  capable  of  activating  plasminogen  is  the  streptokinase 
elaborated by these organisms.  This suggests the possibility that an increase 
of plasmin activity might occur in streptococcal diseases and particularly in ~DGAR W.  ~OgD  323 
rheumatic fever since collagen is known to be affected in this disease.  If this 
occurs, it should be demonstrable in plasmin titrations of rheumatic fever sera 
when azocoll, which contains a  large amount of collagen, is used as the sub- 
strate.  The present investigation seems to show that the opposite phenomenon 
actually occurs in rheumatic fever and that during the most acute phases of 
the disease the potential proteolytic activity is at its lowest.  It is also note- 
worthy that rheumatic fever patients usually develop high titres of antistrepto- 
kinase in their blood which would tend to neutralize any streptokinase absorbed 
from the area of infection. 
The parallel courses of total plasmin  and  inhibitor curves, which suggest 
that a compensatory mechanism may normally regulate the relative quantities 
of these substances in the blood, were most evident in uncomplicated scarlet 
fever.  In these cases the plasmin curve was usually at a  considerably higher 
level on the chart than the inhibitor curve.  In suppurative complications of 
scarlet fever the two curves were relatively approximated due to an average 
lower  plasmin  level  and  an  average  higher  inhibitor  level.  In  cases  that 
developed rheumatic fever there was, on the average, throughout the course of 
the disease, a plasmin level similar to that found in cases with suppuration and 
a  slightly higher inhibitor level.  In  the 4th week,  however, the  cases with 
suppuration maintained their usual levels of plasmin and inhibitor in contrast 
to the rheumatic cases which showed a fall of plasmin accompanied by a marked 
increase of inhibitor which occurred only at this time when rheumatic symptoms 
most  commonly  occurred.  This  characteristic  fall  of  plasmin  and  rise  of 
inhibitor which  occurred in rheumatic  fever might  be  due to suspension or 
reversal of the compensatory mechanism which has already been tentatively 
suggested.  Alternatively,  it  might  be  due  to  a  qualitative  change  in  the 
character of the inhibitor in rheumatic  fever so  that  instead  of being more 
active against  trypsin than against  plasmin  it  becomes more active against 
plasmin  than  against  trypsin.  This  possibility  raises  the  question  of  the 
character and stability of the  trypsin inhibitor in  serum.  It is well known 
that fresh human serum contains a relatively large amount of trypsin inhibitor 
which gradually disappears when the serum is stored in  the cold.  The sera 
used in the present investigation had been stored in the cold for at least a year 
and the sera of the 2 quiescent rheumatic children for 8 years before they were 
titrated for plasmin and inhibitor.  It was shown in the preceding paper (Todd, 
1948) that no significant loss of total plasmin was observed in sera which had 
been stored in the cold for 11 months.  On the other hand, a slow progressive 
loss of inhibitor was noted.  It seems reasonable to suppose that an entirely 
different picture of the relations of total plasmin  to trypsin inhibitor in the 
diseases investigated in this paper might have appeared if the charts had been 
prepared from data obtained by titrating fresh sera for plasmin and inhibitor. 
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and that the inhibitor levels would have been considerably higher than those 
recorded.  Preliminary experiments  with  different  reagents  from those  de- 
scribed in this paper confirm the observation that sera taken at weekly intervals 
from patients with uncomplicated  scarlet fever and stored in the cold for long 
periods tend to give parallel curves of plasmin and of inhibitor levels.  On the 
other hand, fresh sera of a similar nature tend to give plasmin and inhibitor 
levels which are reciprocally related.  This difference between stored and fresh 
sera  cannot be explained  at present.  It probably depends  on the unknown 
nature of trypsin inhibitor in serum,  on whether it is composed of a  single 
substance or  of two or  more  substances,  and on differences in the relative 
stabilities of these possibly multiple substances. 
It can, however, be stated that under the experimental conditions described, 
a marked fall of potential proteolytic activity occurred regularly at the time 
of rheumatic activity and that this phenomenon  rarely occurred  in strepto- 
coccal infections which showed no evidence of rheumatic disease. 
No explanation can be offered at present for the low potential proteolytic 
activity of serum during the acute phase of rheumatic fever. 
SUMMARY 
The  total plasmin and  the  trypsin inhibitor were  titrated separately in 
samples  of serum taken at weekly intervals from three different  groups  of 
scarlet fever patients: (a)  those who did not develop any complications,  (b) 
those who developed  purulent complications,  and  (c)  those who developed 
rheumatic fever. 
When these  determinations were plotted, it  was found that the resulting 
curves showed characteristic patterns for each of the diseases investigated. 
The uncomplicated cases had plasmin curves which were considerably higher 
on the charts than the inhibitor curves. 
The septic cases had plasmin and inhibitor curves which were closer together 
on the charts. 
The rheumatic cases had plasmin  and inhibitor curves  which  were  close 
together and which  crossed  at  the  time of rheumatic activity so  that  the 
inhibitor curve reached a higher level than the plasmin curve. 
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